Riskpilot← Back to searchSign inGet full accessMedigrape Advise AB
ABActiveOrg 5567713358Lilla Vägen 12Medical specialists activities · NACE 8622Est. 20081 employees
Revenue 2025
SEK 633K
+58% vs 2024
EBITDA margin
-15.6%
+91% vs 2024
Equity ratio
11.0%
Financial strength
Net profit 2025
SEK -18K
+78% vs 2024
| Revenue | SEK 633K | +58% |
| EBITDA | SEK -99K | +91% |
| Net profit | SEK -18K | +78% |
| Total assets | SEK 910K | -34% |
| Equity | SEK 100K | -86% |
| Employees | 1 | — |
Legal name
Medigrape Advise AB
Org number
5567713358
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 december 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva ögonmedicinsk konsultation. Bolaget ska även bedriva tjänster och utbildning kring kvalitetsorientering inom honungsproduktion, vinprovning samt övrigt mathantverk. Ytterligare verksamhet rör handel med honungsprodukter. Handel, modifiering och renovering av klassiska fordon.
Address
Lilla Vägen 12
Email
viktoria.bassani@bidrottningen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 638 | 2 755 | 2 126 | 401 | 633 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 989 | 1 129 | 537 | −1 057 | −99 |
| Depreciation & amort. | −3 | −60 | −107 | −107 | −101 |
| EBIT | 986 | 1 069 | 430 | −1 164 | −200 |
| Net financials | — | 211 | −32 | −8 | 3 |
| Profit before tax | 957 | 1 081 | 464 | −83 | −18 |
| Tax | −210 | −182 | −108 | −0 | −0 |
| Net profit | 747 | 899 | 356 | −83 | −18 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 010 | 3 647 | 3 303 | 1 374 | 910 |
| Equity | 1 035 | 1 434 | 1 290 | 707 | 100 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 529 | 544 | 391 | 119 | 442 |
| Total debt | 529 | 544 | 391 | 119 | 442 |
EBITDA margin
-15.6%
This company
15.8%
Market median
-199% vs market
20212025
Equity ratio
11.0%
This company
38.2%
Market median
-71% vs market
20212025
Return on equity
-18.0%
This company
18.4%
Market median
-198% vs market
20212025
Net profit margin
-2.8%
This company
8.1%
Market median
-135% vs market
20212025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
8.10×
This company
0.62×
Market median
-1206% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MA | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medigrape Advise AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Ann-Christin Hansson | Audit | 0 companies |
| Viktoria Elisabeth Bassani | Board of Directors | 0 companies |
| Håkan Fredrik Stjernquist | Deputy Board Member | 0 companies |